Southwest Oncology Group S0600 Treatment Form Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Source Form: NCI FormBuilder:

  1. 8/27/12 8/27/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Colorectal Cancer NCT00499369 Treatment - Southwest Oncology Group S0600 Treatment Form - 2813273v1.0

No Instruction available.

  1. StudyEvent: Southwest Oncology Group S0600 Treatment Form
    1. No Instruction available.
Vital Status
Has the patient progressed per the definition of Section 10.0 of the protocol
Assigned Treatment Arm
Concurrent chemotherapy
Were there any dose modifications or additions/omissions to protocol treatment?
Was G-CSF received
Ccrr Module For Southwest Oncology Group S0303 Treatment Form - Arm 1

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial